Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism.
about
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individualsNAFLD and Chronic Kidney DiseaseMultiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH)Visceral adiposity index: an indicator of adipose tissue dysfunction.Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH)Steatosis and steatohepatitis: complex disorders.Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysisAbdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis.Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.Lipoprotein Profiles in Class III Obese Caucasian and African American Women with Nonalcoholic Fatty Liver Disease.Divergent phenotypes in siblings with identical novel mutations in the HNF-1α gene leading to maturity onset diabetes of the young type 3Polyphenol-Rich Fraction of Ecklonia cava Improves Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed Mice.Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.Sterol regulatory element-binding factor 2 (SREBF-2) predicts 7-year NAFLD incidence and severity of liver disease and lipoprotein and glucose dysmetabolismMitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis.Adipose Tissue Depots and Their Cross-Sectional Associations With Circulating Biomarkers of Metabolic RegulationNonalcoholic Steatohepatitis (NASH) Is Associated with a Decline in Pancreatic Beta Cell (β-Cell) Function.Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls.Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver diseaseSerum ferritin is associated with non-alcoholic fatty liver disease and decreased Β-cell function in non-diabetic men and women.The Serum Oxidative/Anti-oxidative Stress Balance Becomes Dysregulated in Patients with Non-alcoholic Steatohepatitis Associated with Hepatocellular Carcinoma.Ghrelin-ghrelin O-acyltransferase system in the pathogenesis of nonalcoholic fatty liver disease.The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial.Analysis of factors influencing glucose tolerance in Japanese patients with non-alcoholic fatty liver disease.The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD).Hepatic steatosis and non-alcoholic fatty liver disease are not associated with decline in renal function in people with Type 2 diabetes.Adipocytokine expression associated with miRNA regulation and diagnosis of NASH in obese patients with NAFLD.Altered gut-liver axis and hepatic adiponectin expression in OSAS: novel mediators of liver injury in paediatric non-alcoholic fatty liver.Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in patients with obesity.Trans-Fatty Acids Aggravate Obesity, Insulin Resistance and Hepatic Steatosis in C57BL/6 Mice, Possibly by Suppressing the IRS1 Dependent Pathway.Hepatosteatosis and hepatic insulin resistance are blunted by argirein, an anti-inflammatory agent, through normalizing endoplasmic reticulum stress and apoptosis in diabetic liver.MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat.A meal high in saturated fat evokes postprandial dyslipemia, hyperinsulinemia, and altered lipoprotein expression in obese children with and without nonalcoholic fatty liver disease.Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic positron emission tomography study.The therapeutic effects of bee venom on some metabolic and antioxidant parameters associated with HFD-induced non-alcoholic fatty liver in rats.Characteristics of hepatic insulin-sensitive nonalcoholic fatty liver disease.
P2860
Q22299426-3D54FD7E-A224-49C1-8DAF-9BC6EFDAD0F5Q26752759-45FF78A2-842E-4144-ABF5-489BB46D7A32Q27007515-EB5333EF-F267-4316-94DB-E604609113D6Q33563343-7FCCAA63-9B5A-47D3-9AE1-1EC3BC623000Q33755566-B8E58E43-C6AE-4ED0-9072-38DDAF52AD8DQ33907632-1B7DC396-CF68-44B1-AF20-2F67700A947EQ33932951-ED2F4CBB-84F8-45E1-A47D-FBE5B3EA71D1Q34310464-D2C92F37-3D4F-4038-AABF-F702D0DCE990Q34750698-8F25D612-F14D-4246-BE1A-5F7F7DAA6E13Q35850407-A819ABF6-8C97-47A6-A0C1-F5D64C660D24Q36008120-90C78372-BA3E-4817-8472-E21680EB32F9Q36329720-1D356E1D-E915-4908-A572-AEAA930E8C3CQ36465496-4D19DFDC-7FE4-416E-B3D3-86E971CC415AQ36720511-CCB914B8-5230-4B01-BADE-3743E31F262FQ36740555-6A65CE9E-BD6B-408B-8FDB-A407A48D276AQ36956683-B84C8BD6-8A8E-403D-A816-483E4530042CQ36987281-892BBB63-3967-4865-9266-795D7BAC5383Q37375111-B130C144-24B2-4C63-A874-3DA66A890AC5Q37596189-503B418F-16C7-4990-9F4A-94073A5DFE83Q37619238-5BAC2370-D07B-4D81-AFD2-7449EF23245DQ37697255-4297BAE9-205C-4718-92D0-EE5ACAE81519Q38389889-137E10E9-63BB-4530-BCD4-4B682FAC7941Q39275836-3FB98582-29A9-47B6-8C73-D074AB7C9E13Q41611224-BB19CA43-3B39-41F3-BA53-CA98E4568473Q44475268-EAFE8D37-2055-4C8A-883F-D06DA172BFCCQ44682506-10BDC268-EB42-4A4E-B568-47F91C978A11Q45758242-1C4C81CD-DC9D-4154-95CC-B6BD655934FDQ47965667-D70B84AC-F3FE-4EC7-8EB8-F0C0C9D798ACQ49144853-1D3B0FF6-B1A2-40DE-B638-0DAA11A1AD43Q50238634-6F3BC8B1-6B8A-44AC-9990-EAD71CF3A15BQ51016955-DAB04FAE-5EC4-4109-A850-B336248195A4Q51089524-8F983480-20EE-41A2-98F4-639B76A0E9DCQ51347859-F6DE7C62-6990-4625-895F-8C3518A31A2DQ53964243-4B1D153A-CAA8-462B-B0A0-F6D60B10BB28Q55168115-3E67F1B6-8395-47FF-8712-2EA9B579B93BQ55462318-7DDBCB6D-0DB9-4538-ABAF-8EC34DFC4162
P2860
Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Nonalcoholic steatohepatitis v ...... se and lipoprotein metabolism.
@en
Nonalcoholic steatohepatitis v ...... se and lipoprotein metabolism.
@nl
type
label
Nonalcoholic steatohepatitis v ...... se and lipoprotein metabolism.
@en
Nonalcoholic steatohepatitis v ...... se and lipoprotein metabolism.
@nl
prefLabel
Nonalcoholic steatohepatitis v ...... se and lipoprotein metabolism.
@en
Nonalcoholic steatohepatitis v ...... se and lipoprotein metabolism.
@nl
P2093
P2860
P921
P356
P1433
P1476
Nonalcoholic steatohepatitis v ...... se and lipoprotein metabolism.
@en
P2093
Fabio Orlandi
Floriano Rosina
Franco De Michieli
Giovanni Musso
Maurizio Cassader
Roberto Gambino
P2860
P304
P356
10.1002/HEP.25739
P407
P577
2012-07-03T00:00:00Z